Johnson & Johnson Vision Care
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johnson & Johnson Vision Care sits in the top decile of US sponsors by registered trial count (#197 of 15,742 sponsors by registered trial count).
Johnson & Johnson Vision Care: 142 sponsored US clinical trials, 1 recruiting.
Johnson & Johnson Vision Care sponsors 142 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 139 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Visual Acuity, with 19 trials.
Top-decile sponsor footprint
Johnson & Johnson Vision Care ranks in the top decile of sponsors by registered trial count (#197 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
139 of 141 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
142 total, page 3 of 3
Evaluation of an Investigational Multifocal Lens
NCT02223754
A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian Eyes
NCT02036320
Evaluation of Etafilcon A Daily Disposable Lenses
NCT02061592
Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses
NCT01990664
Senofilcon A Investigational Manufacturing Process
NCT01951703
Toric Eye Strain and Stability Study
NCT01857102
Contact Lens Comfort Relative to Meibomian Gland Status
NCT01819194
Clinical and Laboratory Evaluation of 3 Contact Lenses With 4 Contact Lens Solutions
NCT01791517
Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population
NCT01763047
Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear
NCT01669629
Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens
NCT01484054
Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
NCT01484028
Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY
NCT01467557
Mucin Balls and Corneal Inflammation Events
NCT01437319
Study of ACUVUE® ADVANCE® PLUS Contact Lenses.
NCT01244893
Pilot Dispensing Evaluation of a Plus Power Lens
NCT01228591
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
NCT01244516
Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens
NCT01192542
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
NCT01180777
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
NCT01180985
Myopia Progression After Ceasing Myopia Control Contact Lens Wear
NCT01829230
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
NCT01094730
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
NCT01151371
Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types
NCT01120782
Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens
NCT01094743
Dispensing Evaluation of New Daily Disposable Toric Soft Contact Lens.
NCT01055132
Assessment of Daily Disposable Silicone Hydrogel Lens Wear
NCT01093625
Vistakon Investigational Multi-purpose Contact Lens Care Solution.
NCT01055457
Investigational Multi-purpose Contact Lens Care Solution.
NCT01055613
Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients
NCT01016652
Vistakon Investigational Lens Worn as a Single Use Daily Wear
NCT01031004
Clinical Performance Comparison of Two Contact Lenses
NCT00975585
Comparison of Three Soft Bifocal Contact Lenses
NCT00808340
Clinical Evaluation of the Long-Term Effects of Contact Lens Care Systems
NCT00813761
Comparison of Two Soft Bifocal Contact Lenses
NCT00724945
A Comparison of Two Contact Lenses
NCT00700752
Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)
NCT01829191
Comparison of Two Toric Contact Lenses on Current Toric Wearers
NCT00639379
Performance of Two Silicone Hydrogel Toric Contact Lenses
NCT00638846
Vistakon Investigational Contact Lenses Worn for Daily Wear
NCT00717249
Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period
NCT00762502
Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).
NCT00241280
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Johnson & Johnson Vision Care pipeline
1 recruiting of 142 indexed (1% open); 139 completed (98%).
Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Visual Acuity (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johnson & Johnson Vision Care: open-pipeline peers nationwide
Peers matched on 142 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
Johnson & Johnson Vision Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 142 trials (± recruiting share)
- Case Western Reserve University · 141 trials · 16% recruiting
- Eastern Cooperative Oncology Group · 141 trials · 3% recruiting
- Purdue University · 141 trials · 10% recruiting
- Radiation Therapy Oncology Group · 144 trials · 0% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Mylan Pharmaceuticals · 1% recruiting · 146 trials
- Gynecologic Oncology Group · 1% recruiting · 154 trials
- Shire · 0% recruiting · 245 trials
- Abbott Nutrition · 1% recruiting · 89 trials
Related
What to do with this Johnson & Johnson Vision Care page
142 registered trials is a research-attention snapshot, not an endorsement of Johnson & Johnson Vision Care or any single study.
- 1 of Johnson & Johnson Vision Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Visual Acuity is the condition Johnson & Johnson Vision Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Visual Acuity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Johnson & Johnson Vision Care pipeline card: 142 registered trials from official public datasets.Report a data error.